Discussion

1 to 50 of 2507 threads (6.8K total posts)
Thread Subject Replies Last Post
alternative dosing schedules for carfilzomib
0 10 hours ago by Krista Voytilla
BMI 61 & R-CHOP
2 21 hours ago by Teresa Meier
Natural Medicine / Herbal / Homeopathic Reference recommendation
3 23 hours ago by Jennifer Sanderson
Original post by David Kwasny
High-Yield Med Review and BCOP Exam
1 yesterday by Glenn Roma
Original post by Lisa Raff
Bevacizuamb infusion times
5 4 days ago by Gayle Blouin
Original post by Jamie Wiggins-Craig
BCOP Review Course 2019
1 4 days ago by Bethany Sibbitt
Original post by Stephanie Beam
Pediatric CAR-T Cell Policy
0 5 days ago by Sarah Hansen
patient education video - biologics/immunotherapy
0 5 days ago by Douglas Smith
cardiac monitoring with Rituxan
1 6 days ago by Kendall Yake
Original post by Susan Hauswirth
Chemo transport bag
1 6 days ago by Kendall Yake
Original post by Susan Hauswirth
Splenectomy Vaccines & Chemotherapy
1 6 days ago by Stephen Clark
Original post by Teresa Meier
IT Prophylaxis in ALL
0 6 days ago by Jeffrey Baron
Rasburicase
1 7 days ago by Junyu Zhang
Original post by Dawn Lafleur
tumor fever
0 8 days ago by Nguyen Le Trang
Interface between Mosaiq and cerner
0 8 days ago by Hongchao Liu
CALGB 10403 in Ph+
0 8 days ago by Morgan Culver
FLOT4 sequence of administration
6 8 days ago by Jamie Joy
Original post by Debra Chibroski
Cannabis for Nausea
0 9 days ago by Jeff Lombardo
HD MTX Discharge Levels
0 11 days ago by Marissa Ausman
reason for loading dose in HDMTX for hyperCVAD?
1 11 days ago by Deborah Hass
Original post by Robin Mower
shortening 24 hour chemo intervals for continuous infusions or intermittent infusions
3 12 days ago by Stephen Clark
Original post by Kathlene DeGregory
Pediatric Oncology Clinical Pharmacy Services
0 12 days ago by Lindsay Robusto
Beacon Infusion Table
0 12 days ago by Tina Cabala
Darzalex over 90 minutes
7 12 days ago by Kirollos Hanna
Original post by Sara Fleszar
0.2 micron filter (random question)
1 13 days ago by Junyu Zhang
Original post by Brian Cochran
antiemetic dexamethasone for 7+3
3 13 days ago by Justin Huynh
Original post by Alan Fisher
IDS Fees for Federally-Funded Studies
1 13 days ago by Morgan Kelly
Original post by Douglas Parr
Oncology Pharmacy Consult Agreement
0 13 days ago by Meghan Sullivan
Trastuzumab-mfolfox for esophageal adenocarcinoma
1 13 days ago by Steven Townsend
Original post by Susan Hauswirth
Cyclophosphamide Vial - Beyond Use Date?
0 18 days ago by Raja Bhatt
obinutuzumab with Rituximab allergy
4 18 days ago by Teresa Slagle
Original post by Janice Lindsey
dosi-fuser
1 19 days ago by Meghan Aslanian
Original post by Janice Lindsey
Brentuximab + AVD for newly diagnosed HL
8 19 days ago by Caroline Carson
Original post by Stephen Clark
Investigational Drug Service Pharmacy Staffing
4 19 days ago by Camille Smith
Original post by Christopher Allen
Pegasparginase Pre-medication and Monitoring
0 20 days ago by Angela Duenn
Translation into Chinese
1 21 days ago by Teresa Slagle
Original post by Dawn Lafleur
Midostaurin + Idarubicin
3 24 days ago by Mohamed Sadek
Original post by Julie Moeller
Indomethacin oral spray
1 26 days ago by Sunao Slayton
Original post by Robert Cade
Lupron (leuprolide acetate) as Hazadous Drug?
4 26 days ago by Steven Townsend
Original post by Timothy Tyler
Outpatient Formulary conversions within Epic
0 26 days ago by Alexander Quesenberry, PharmD
Rydapt for inpatients
7 26 days ago by Matthew Smith
Original post by Robin Mower
Lutathera
2 27 days ago by Jennifer Collins
Original post by Cynthia Barlow
Dexrazoxane for extravasation
1 27 days ago by Christine Noel
Original post by Kristina Frinzi
delivery of chemo
2 27 days ago by Kristin Henseleit
Original post by Steven Townsend
Disposal of old HEPA filter from BSC
1 28 days ago by Lisa Raff
Original post by Debra Chibroski
Dose rounding policy
64 28 days ago by Ramesh Neerpat
Original post by Sunao Slayton
NIOSH/assessment of risk buddies?
1 28 days ago by Merri Avino
Original post by Nick Crozier
Keytruda (pembrolizumab) or Tecentriq (atezolizumab): FDA Alerts Health Care Professionals and Investigators: FDA Statement - Decreased Survival in Some Patients in Clinical Trials Associated with Monotherapy
0 one month ago by Dung Chau
IV ondansetron shortage
1 one month ago by Shawn Giess
Original post by Vanessa Lehnhardt
TACE Dosing and Procedure
0 one month ago by Cameron Ninos